FI58920C - Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner - Google Patents

Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner Download PDF

Info

Publication number
FI58920C
FI58920C FI1819/74A FI181974A FI58920C FI 58920 C FI58920 C FI 58920C FI 1819/74 A FI1819/74 A FI 1819/74A FI 181974 A FI181974 A FI 181974A FI 58920 C FI58920 C FI 58920C
Authority
FI
Finland
Prior art keywords
methyl
oxohexyl
xanthine
oxoalkyl
propylxanthine
Prior art date
Application number
FI1819/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI58920B (fi
FI181974A (sv
Inventor
Werner Mohler
Manfred Jayme
Jaromir Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI181974A publication Critical patent/FI181974A/fi
Publication of FI58920B publication Critical patent/FI58920B/fi
Application granted granted Critical
Publication of FI58920C publication Critical patent/FI58920C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
FI1819/74A 1973-06-16 1974-06-14 Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner FI58920C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (de) 1973-06-16 1973-06-16 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2330742 1973-06-16

Publications (3)

Publication Number Publication Date
FI181974A FI181974A (sv) 1974-12-17
FI58920B FI58920B (fi) 1981-01-30
FI58920C true FI58920C (fi) 1981-05-11

Family

ID=5884209

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1819/74A FI58920C (fi) 1973-06-16 1974-06-14 Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner

Country Status (17)

Country Link
US (1) US4289776A (sv)
JP (1) JPS5233120B2 (sv)
AR (3) AR208179A1 (sv)
AT (1) AT334388B (sv)
BE (1) BE816332A (sv)
CH (2) CH612969A5 (sv)
DE (1) DE2330742C2 (sv)
DK (1) DK145676C (sv)
ES (1) ES427171A1 (sv)
FI (1) FI58920C (sv)
FR (1) FR2233065B1 (sv)
GB (1) GB1470220A (sv)
IE (1) IE39898B1 (sv)
NL (1) NL182806C (sv)
NO (1) NO140300C (sv)
SE (1) SE423631B (sv)
ZA (1) ZA743760B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (sv) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0042706B1 (en) * 1980-06-21 1985-12-27 BEECHAM - WUELFING GmbH & Co. KG Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0514789B1 (de) * 1991-05-23 1996-09-11 Hoechst Aktiengesellschaft Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
AU1868195A (en) * 1994-01-28 1995-08-15 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
JP5567503B2 (ja) 2008-02-29 2014-08-06 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US8952016B2 (en) 2009-02-27 2015-02-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP3397640B1 (en) * 2015-12-29 2021-08-04 INSERM - Institut National de la Santé et de la Recherche Médicale Xanthine derivative inhibitors of bet proteins
CN112724160A (zh) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 一种己酮可可碱杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1233405B (de) 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1545689C2 (de) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Methyl-3-carbäthoxy-5,6-dihydropyran
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
JPS5047992A (sv) 1975-04-28
ZA743760B (en) 1975-06-25
NL182806C (nl) 1988-05-16
NO140300B (no) 1979-04-30
AT334388B (de) 1976-01-10
NO140300C (no) 1979-08-08
ES427171A1 (es) 1976-07-16
FI58920B (fi) 1981-01-30
FI181974A (sv) 1974-12-17
NO742121L (sv) 1975-01-13
AR209320A1 (es) 1977-04-15
DE2330742C2 (de) 1982-07-29
FR2233065B1 (sv) 1978-07-21
BE816332A (fr) 1974-12-16
JPS5233120B2 (sv) 1977-08-26
AR208179A1 (es) 1976-12-09
DK145676C (da) 1983-08-01
CH608807A5 (sv) 1979-01-31
DK321574A (sv) 1975-02-10
IE39898B1 (en) 1979-01-31
NL7407890A (sv) 1974-12-18
AU7014774A (en) 1975-12-18
NL182806B (nl) 1987-12-16
ATA491874A (de) 1976-05-15
AR209319A1 (es) 1977-04-15
SE423631B (sv) 1982-05-17
DE2330742A1 (de) 1975-01-09
IE39898L (en) 1974-12-16
FR2233065A1 (sv) 1975-01-10
US4289776A (en) 1981-09-15
SE7407913L (sv) 1974-12-17
CH612969A5 (sv) 1979-08-31
GB1470220A (en) 1977-04-14
DK145676B (da) 1983-01-24

Similar Documents

Publication Publication Date Title
FI58920C (fi) Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner
US4438128A (en) Cardioactive aryloxypropanolamines
Novinson et al. 2-(Alkylthio)-1, 2, 4-triazolo [1, 5-a] pyrimidines as adenosine 3', 5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents
HU180219B (en) Process for producing substituted xantine derivatives and salts
JP2002509921A (ja) サイクリン依存性キナーゼ阻害剤
CA1244411A (en) Aminodesoxy-1.4;3.6-dianhydrohexitol nitrates, processes for their preparation and pharmaceutical composition
US3463850A (en) Arabinofuranosyl 2-thiopyrimidines and pharmaceutical compositions thereof
FI64370B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido(6,1-a)isokinolin-2-imino-4-onderivat
NO762661L (sv)
SE468560B (sv) 1-(hydroxistyryl)-5h-2,3-bensodiazepinderivat, foerfarande foer deras framstaellning samt farmaceutiska kompositioner innehaallande desamma
PL150841B1 (en) Purine compounds.
US3734911A (en) Dialkyl-xanthine derivatives
EP0044704B1 (en) Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, and pharmaceutical compositions containing them
US4060616A (en) Purine derivatives with repeating unit
US4232023A (en) Novel soluble derivatives of 2,4-diamino pyrimidine
US4942143A (en) Imidazothiadiazine derivatives, and their use as medicaments
US5583225A (en) Syntheses of acyclic guanine nucleosides
US4049816A (en) Antiviral 2-amino-5-[1-(indol-3-yl)alkyl]-2-thiazolin-4-ones
NO135983B (sv)
FI57589C (fi) Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner
CA1075690A (en) Xanthine derivatives
US3989833A (en) Pharmaceutical compositions containing adenine derivatives
PT97045A (pt) Processo para a preparacao de labdanos e de composicoes farmaceuticas que os contem
EP0044932A1 (de) Gegebenenfalls N-substituierte Amino-desoxy-1.4;3.6-dianhydro-hexit-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung
EP0136198A1 (fr) Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques